212 related articles for article (PubMed ID: 25468916)
1. Spatial and temporal cancer evolution: causes and consequences of tumour diversity.
Hiley CT; Swanton C
Clin Med (Lond); 2014 Dec; 14 Suppl 6():s33-7. PubMed ID: 25468916
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
Kim JY; Gatenby RA
Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
[TBL] [Abstract][Full Text] [Related]
3. Tumour heterogeneity and resistance to cancer therapies.
Dagogo-Jack I; Shaw AT
Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.
Murtaza M; Dawson SJ; Tsui DW; Gale D; Forshew T; Piskorz AM; Parkinson C; Chin SF; Kingsbury Z; Wong AS; Marass F; Humphray S; Hadfield J; Bentley D; Chin TM; Brenton JD; Caldas C; Rosenfeld N
Nature; 2013 May; 497(7447):108-12. PubMed ID: 23563269
[TBL] [Abstract][Full Text] [Related]
5. Advances in understanding tumour evolution through single-cell sequencing.
Kuipers J; Jahn K; Beerenwinkel N
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):127-138. PubMed ID: 28193548
[TBL] [Abstract][Full Text] [Related]
6. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.
Gerlinger M; Swanton C
Br J Cancer; 2010 Oct; 103(8):1139-43. PubMed ID: 20877357
[TBL] [Abstract][Full Text] [Related]
7. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
8. Tumour heterogeneity and cancer cell plasticity.
Meacham CE; Morrison SJ
Nature; 2013 Sep; 501(7467):328-37. PubMed ID: 24048065
[TBL] [Abstract][Full Text] [Related]
9. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.
Ling S; Hu Z; Yang Z; Yang F; Li Y; Lin P; Chen K; Dong L; Cao L; Tao Y; Hao L; Chen Q; Gong Q; Wu D; Li W; Zhao W; Tian X; Hao C; Hungate EA; Catenacci DV; Hudson RR; Li WH; Lu X; Wu CI
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6496-505. PubMed ID: 26561581
[TBL] [Abstract][Full Text] [Related]
10. Translational implications of tumor heterogeneity.
Jamal-Hanjani M; Quezada SA; Larkin J; Swanton C
Clin Cancer Res; 2015 Mar; 21(6):1258-66. PubMed ID: 25770293
[TBL] [Abstract][Full Text] [Related]
11. Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.
Hollstein M; Alexandrov LB; Wild CP; Ardin M; Zavadil J
Oncogene; 2017 Jan; 36(2):158-167. PubMed ID: 27270430
[TBL] [Abstract][Full Text] [Related]
12. Inferring mutational timing and reconstructing tumour evolutionary histories.
Turajlic S; McGranahan N; Swanton C
Biochim Biophys Acta; 2015 Apr; 1855(2):264-75. PubMed ID: 25827356
[TBL] [Abstract][Full Text] [Related]
13. A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity.
Waclaw B; Bozic I; Pittman ME; Hruban RH; Vogelstein B; Nowak MA
Nature; 2015 Sep; 525(7568):261-4. PubMed ID: 26308893
[TBL] [Abstract][Full Text] [Related]
14. Natural selection: The evolution of cancer.
Goymer P
Nature; 2008 Aug; 454(7208):1046-8. PubMed ID: 18756229
[No Abstract] [Full Text] [Related]
15. Tumour heterogeneity and the evolution of polyclonal drug resistance.
Burrell RA; Swanton C
Mol Oncol; 2014 Sep; 8(6):1095-111. PubMed ID: 25087573
[TBL] [Abstract][Full Text] [Related]
16. The causes and consequences of genetic heterogeneity in cancer evolution.
Burrell RA; McGranahan N; Bartek J; Swanton C
Nature; 2013 Sep; 501(7467):338-45. PubMed ID: 24048066
[TBL] [Abstract][Full Text] [Related]
17. Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions.
Schmelz K; Toedling J; Huska M; Cwikla MC; Kruetzfeldt LM; Proba J; Ambros PF; Ambros IM; Boral S; Lodrini M; Chen CY; Burkert M; Guergen D; Szymansky A; Astrahantseff K; Kuenkele A; Haase K; Fischer M; Deubzer HE; Hertwig F; Hundsdoerfer P; Henssen AG; Schwarz RF; Schulte JH; Eggert A
Nat Commun; 2021 Nov; 12(1):6804. PubMed ID: 34815394
[TBL] [Abstract][Full Text] [Related]
18. Re-Evaluating Clonal Dominance in Cancer Evolution.
Burrell RA; Swanton C
Trends Cancer; 2016 May; 2(5):263-276. PubMed ID: 28741512
[TBL] [Abstract][Full Text] [Related]
19. Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome.
Venkatesan S; Swanton C
Am Soc Clin Oncol Educ Book; 2016; 35():e141-9. PubMed ID: 27249716
[TBL] [Abstract][Full Text] [Related]
20. Computational Approaches for the Investigation of Intra-tumor Heterogeneity and Clonal Evolution from Bulk Sequencing Data in Precision Oncology Applications.
Laganà A
Adv Exp Med Biol; 2022; 1361():101-118. PubMed ID: 35230685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
